All In MedTech

FDA Clearance Tracker · P200046-S008

Harmony™ Transcatheter Pulmonary Valve

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 8, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 8, 2022

Approved

Time to decision

28 days

Received Mar 11, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

The decision

FDA number
P200046-S008
Device name
Harmony™ Transcatheter Pulmonary Valve
Applicant location
Santa Rosa, CA
Received
Mar 11, 2022
Decided
Apr 8, 2022
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P200046

Device type

Every decision under product code NPV

FDA's approval statement

As written in FDA's record.

Approval of the revised protocols for the post-approval studies.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.